MRA Advisory Group’s Globus Medical GMED Stock Holding History

MRA Advisory Group’s Portfolio GMED Stock Details GMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-5,408	Closed	-$396K	–	149
2025 Q1	$396K	Buy	+5,408	New	+$447K	0.21%	67

Other funds holding GMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BAM

Burgundy Asset Management Toronto, Ontario, Canada $10.6B AUM 13.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

HRCM

Hawk Ridge Capital Management Los Angeles, California $2.75B AUM 20.09% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

MRA Advisory Group's GMED Position: Q2 2025 in Review

MRA Advisory Group sold out of Globus Medical (GMED) in Q2 2025, closing a stake of 5,408 shares — an estimated $396K sold.

MRA Advisory Group first reported a position in GMED in Q1 2025 and held it in 1 quarter. The position peaked at $396K in Q1 2025. 480 funds tracked by Wall St. Rank hold GMED as of Q2 2025.

MRA Advisory Group reported no remaining Globus Medical position as of Q2 2025 after selling out during the quarter.
MRA Advisory Group sold 5,408 Globus Medical shares in Q2 2025, an estimated $396K.
MRA Advisory Group first reported a position in Globus Medical in Q1 2025 and held it in 1 quarter.
MRA Advisory Group's Globus Medical position peaked at $396K in Q1 2025.
480 funds tracked by Wall St. Rank held Globus Medical as of Q2 2025.

Based on MRA Advisory Group's 13F filing for Q2 2025, filed 8 Jul 2025.